rs200811033

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1

The NM_002458.3(MUC5B):​c.8900A>G​(p.Asn2967Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0291 in 1,612,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 0 hom., cov: 28)
Exomes 𝑓: 0.030 ( 0 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.09

Publications

5 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM2
Variant has high frequency in the NFE (0.0318) population. However there is too low homozygotes in high coverage region: (expected more than 341, got 0).
BP4
Computational evidence support a benign effect (MetaRNN=0.0020525157).
BP6
Variant 11-1245780-A-G is Benign according to our data. Variant chr11-1245780-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 403184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0245 (3710/151184) while in subpopulation NFE AF = 0.0323 (2188/67844). AF 95% confidence interval is 0.0311. There are 0 homozygotes in GnomAd4. There are 1853 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.8900A>G p.Asn2967Ser missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2
MUC5B-AS1NR_157183.1 linkn.57-3142T>C intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.8900A>G p.Asn2967Ser missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1
MUC5B-AS1ENST00000532061.2 linkn.57-3142T>C intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3711
AN:
151066
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0124
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00750
Gnomad ASJ
AF:
0.0278
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00815
Gnomad FIN
AF:
0.0681
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0322
Gnomad OTH
AF:
0.0226
GnomAD2 exomes
AF:
0.0261
AC:
6489
AN:
248850
AF XY:
0.0258
show subpopulations
Gnomad AFR exome
AF:
0.0135
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.0284
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0720
Gnomad NFE exome
AF:
0.0339
Gnomad OTH exome
AF:
0.0273
GnomAD4 exome
AF:
0.0296
AC:
43214
AN:
1461270
Hom.:
0
Cov.:
55
AF XY:
0.0290
AC XY:
21050
AN XY:
726916
show subpopulations
African (AFR)
AF:
0.0111
AC:
370
AN:
33418
American (AMR)
AF:
0.00559
AC:
250
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0289
AC:
755
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00933
AC:
805
AN:
86248
European-Finnish (FIN)
AF:
0.0702
AC:
3733
AN:
53212
Middle Eastern (MID)
AF:
0.00474
AC:
27
AN:
5702
European-Non Finnish (NFE)
AF:
0.0321
AC:
35651
AN:
1111810
Other (OTH)
AF:
0.0269
AC:
1623
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
3716
7431
11147
14862
18578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
1332
2664
3996
5328
6660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0245
AC:
3710
AN:
151184
Hom.:
0
Cov.:
28
AF XY:
0.0251
AC XY:
1853
AN XY:
73872
show subpopulations
African (AFR)
AF:
0.0123
AC:
504
AN:
40878
American (AMR)
AF:
0.00749
AC:
114
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.0278
AC:
96
AN:
3458
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5120
South Asian (SAS)
AF:
0.00816
AC:
39
AN:
4780
European-Finnish (FIN)
AF:
0.0681
AC:
720
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0323
AC:
2188
AN:
67844
Other (OTH)
AF:
0.0224
AC:
47
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
189
378
566
755
944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0277
Hom.:
0
ESP6500AA
AF:
0.0105
AC:
41
ESP6500EA
AF:
0.0311
AC:
256
ExAC
AF:
0.0273
AC:
3297

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.7
DANN
Benign
0.80
DEOGEN2
Benign
0.022
T
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.061
N
LIST_S2
Benign
0.19
T
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.1
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.92
N
REVEL
Benign
0.020
Sift
Benign
0.44
T
Vest4
0.068
ClinPred
0.0014
T
GERP RS
0.66
Varity_R
0.030
gMVP
0.76
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200811033; hg19: chr11-1267010; COSMIC: COSV71594260; API